BNP PARIBAS ARBITRAGE, SA
Position in MDGL — Madrigal Pharmaceuticals, Inc.
CIK 1166588
NEW YORK, NY
Position in MDGL
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$31,142,026
+$1,211,582 QoQ
Shares Held
57,998
+1.4% QoQ
Ownership
0.251%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#60
of 411 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in MDGL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BNP PARIBAS ARBITRAGE, SA holds $3,275,701,265 across 414 Biotechnology names. MDGL ranks #36 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
4,377,120 | $306,529,713 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
399,847 | $249,320,598 | |
| 3 | ARGX |
Argenx SE
|
157,958 | $146,548,693 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
262,258 | $130,271,416 | |
| 5 | BNTX |
BioNTech SE
|
1,319,517 | $122,781,056 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
552,710 | $103,511,528 | |
| 7 | ORKA |
Oruka Therapeutics, Inc.
|
1,079,015 | $102,689,857 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,155,442 | $86,057,320 |
All Filings in MDGL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $31,142,026 | 57,998 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $29,930,444 | 57,177 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $42,922,534 | 73,707 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $32,453,405 | 70,757 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $20,893,357 | 69,037 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,151,355 | 3,476 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $2,135,612 | 6,921 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,072,752 | 9,767 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,388,472 | 4,956 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $3,037,312 | 11,374 | Shares | Defined | 2024-05-01 | |
| 2023-12-31 | $5,268,291 | 22,769 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,427,330 | 16,621 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,285,052 | 9,892 | Shares | Defined | 2023-08-09 | |
| 2023-03-31 | $3,238,773 | 13,369 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $13,584,861 | 46,804 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,404,043 | 21,604 | Shares | Defined | 2022-11-16 | |
| 2022-06-30 | $197,274 | 2,756 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $97,335 | 992 | Shares | Defined | 2022-05-18 | |
| 2021-12-31 | $210,409 | 2,483 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $164,447 | 2,061 | Shares | Defined | 2021-11-16 | |
| 2021-06-30 | $41,594 | 427 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $124,222 | 1,062 | Shares | Defined | 2021-05-07 | |
| 2020-12-31 | $106,056 | 954 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $243,871 | 2,054 | Shares | Defined | 2020-10-30 | |
| 2020-06-30 | $182,672 | 1,613 | Shares | Defined | 2020-08-06 | |
| 2020-03-31 | $382,868 | 5,735 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||